acetylethyleneimine,
BIPM cpd,
BP-MAL,
N-(4-(2-benzimidazolyl)phenyl)maleimide,
N-(p-(2-benzimidazolyl)phenyl)maleimide,
N-(p-(benzimidazol-2-yl)phenyl)maleimide,
27030-97-3,
N-[4-(2-Benzimidazolyl)phenyl]maleimide,
BIPM,
1-(4-(1H-Benzo[d]imidazol-2-yl)phenyl)-1H-pyrrole-2,5-dione,
N-(4-(2-Benzimidazolyl)phenyl)maleimide,
UNII-464U78G56E,
N-(p-(2-Benzimidazolyl)phenyl)maleimide,
464U78G56E,
1H-Pyrrole-2,5-dione, 1-[4-(1H-benzimidazol-2-yl)phenyl]-,
1H-Pyrrole-2,5-dione, 1-(4-(1H-benzimidazol-2-yl)phenyl)-,
EINECS 248-173-3,
ACMC-1CMGM,
AC1L3LTB,
AC1Q6CPK,
SCHEMBL179732,
DTXSID4067274,
CTK4F8963,
ZINC2584390,
ANW-26112,
MFCD00042767,
AKOS015854281,
KS-0000140C,
TR-012199,
FT-0706059,
C-48108,
1-[4-(1H-benzimidazol-2-yl)phenyl]pyrrole-2,5-dione,
1-(4-(1H-Benzimidazol-2-yl)phenyl)-1H-pyrrole-2,5-dione,
1H-Pyrrole-2,5-dione,1-[4-(1H-benzimidazol-2-yl)phenyl]-,
N-[4-(2-Benzimidazolyl)phenyl]maleimide, BioReagent, suitable for fluorescence, >=98.0% (HPLC),
N-[4- PHENYL]MALEIMIDE,
C17H11N3O2,
AR-1J8695,
CID117909,
C17-H11-N3-O2,
B1149,
1-[4-(1H-benzimidazol-2-yl)phenyl]-1H-pyrrole-2,5-dione,
27922-19-6,